Inflammatory status of children in the different clinical groups
| . | CC . | DC . | UM . | CM . | SMA . |
|---|---|---|---|---|---|
| IL-1β, pg/mL | 0.89 (0.22-3.81) | 2.01 (0.48-2.90) | 3.79* (1.45-5.81) | 1.12† (0.36-2.44) | 2.88*‡§ (1.94-5.97) |
| IL-4, pg/mL | 5.64 (1.61-25.04) | 3.22* (1.61-3.76) | 3.76* (1.88-5.64) | 1.88*† (1.61-1.88) | 3.22§ (1.61-3.76) |
| IL-6, pg/mL | 6.80 (2.99-19.82) | 21.35* (9.82-73.67) | 195.57*‡ (77.46-433.10) | 75.30*† (21.53-140.27) | 55.39*‡ (35.39-163.73) |
| IL-8, pg/mL | 392.59 (103.44-1127.22) | 51.29* (21.50-418.11) | 69.95* (30.79-141.90) | 39.04* (13.47-153.80) | 45.68* (27.78-227.82) |
| IL-10, pg/mL | 7.44 (3.70-13.45) | 15.94* (5.31-37.19) | 730.18*‡ (240.77-1900.77) | 76.55*†‡ (45.80-489.80) | 199.69*†‡ (112.37-397.60) |
| TNF-α, pg/mL | 1.80 (0.90-6.12) | 1.80 (0.66-2.70) | 4.60*‡ (2.70-11.68) | 1.80† (0.66-3.29) | 3.44‡ (0.98-6.57) |
| GM-CSF, pg/mL | 1.04 (0.93-2.87) | 0.52* (0-0.93) | 2.78*‡ (0.93-4.63) | 0.93† (0.51-1.70) | 1.24‡ (0.93-2.73) |
| Ferritin, ng/mL | 99.35 (55.07-154.10) | 536.50* (144.10-755.30) | 313.40* (176.70-509.80) | 539.70*‡ (363.40-985.90) | 583.20*† (472.10-985.90) |
| Serum hepcidin, standardized peak intensity (m/z) | −0.43 (−0.46 to −0.37) | −0.44 (−0.48 to −0.36) | 0.11*‡ (−0.38 to 1.037) | −0.22*† (−0.43 to 0.62) | −0.38† (−0.48 to 0.25) |
| . | CC . | DC . | UM . | CM . | SMA . |
|---|---|---|---|---|---|
| IL-1β, pg/mL | 0.89 (0.22-3.81) | 2.01 (0.48-2.90) | 3.79* (1.45-5.81) | 1.12† (0.36-2.44) | 2.88*‡§ (1.94-5.97) |
| IL-4, pg/mL | 5.64 (1.61-25.04) | 3.22* (1.61-3.76) | 3.76* (1.88-5.64) | 1.88*† (1.61-1.88) | 3.22§ (1.61-3.76) |
| IL-6, pg/mL | 6.80 (2.99-19.82) | 21.35* (9.82-73.67) | 195.57*‡ (77.46-433.10) | 75.30*† (21.53-140.27) | 55.39*‡ (35.39-163.73) |
| IL-8, pg/mL | 392.59 (103.44-1127.22) | 51.29* (21.50-418.11) | 69.95* (30.79-141.90) | 39.04* (13.47-153.80) | 45.68* (27.78-227.82) |
| IL-10, pg/mL | 7.44 (3.70-13.45) | 15.94* (5.31-37.19) | 730.18*‡ (240.77-1900.77) | 76.55*†‡ (45.80-489.80) | 199.69*†‡ (112.37-397.60) |
| TNF-α, pg/mL | 1.80 (0.90-6.12) | 1.80 (0.66-2.70) | 4.60*‡ (2.70-11.68) | 1.80† (0.66-3.29) | 3.44‡ (0.98-6.57) |
| GM-CSF, pg/mL | 1.04 (0.93-2.87) | 0.52* (0-0.93) | 2.78*‡ (0.93-4.63) | 0.93† (0.51-1.70) | 1.24‡ (0.93-2.73) |
| Ferritin, ng/mL | 99.35 (55.07-154.10) | 536.50* (144.10-755.30) | 313.40* (176.70-509.80) | 539.70*‡ (363.40-985.90) | 583.20*† (472.10-985.90) |
| Serum hepcidin, standardized peak intensity (m/z) | −0.43 (−0.46 to −0.37) | −0.44 (−0.48 to −0.36) | 0.11*‡ (−0.38 to 1.037) | −0.22*† (−0.43 to 0.62) | −0.38† (−0.48 to 0.25) |